| Product Code: ETC9627566 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Plant Derivative Drugs Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Plant Derivative Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Plant Derivative Drugs Market - Industry Life Cycle |
3.4 Taiwan Plant Derivative Drugs Market - Porter's Five Forces |
3.5 Taiwan Plant Derivative Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Plant Derivative Drugs Market Revenues & Volume Share, By Therapeutics Application, 2021 & 2031F |
3.7 Taiwan Plant Derivative Drugs Market Revenues & Volume Share, By Dosage Type, 2021 & 2031F |
3.8 Taiwan Plant Derivative Drugs Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Taiwan Plant Derivative Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for natural and organic products in the pharmaceutical industry |
4.2.2 Growing awareness about the benefits of plant-based medicines |
4.2.3 Favorable government regulations promoting the use of plant derivative drugs |
4.3 Market Restraints |
4.3.1 Limited research and development in the field of plant derivative drugs |
4.3.2 Challenges in standardization and quality control of plant-based pharmaceuticals |
4.3.3 Competition from synthetic drugs and traditional medicines |
5 Taiwan Plant Derivative Drugs Market Trends |
6 Taiwan Plant Derivative Drugs Market, By Types |
6.1 Taiwan Plant Derivative Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Terpenes, 2021- 2031F |
6.1.4 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.5 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Glycoside, 2021- 2031F |
6.1.6 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Phenols, 2021- 2031F |
6.1.7 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Plant Derivative Drugs Market, By Therapeutics Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.2.4 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Central Nervous System disorders, 2021- 2031F |
6.2.5 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.6 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.7 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.3 Taiwan Plant Derivative Drugs Market, By Dosage Type |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Liquid, 2021- 2031F |
6.3.4 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Taiwan Plant Derivative Drugs Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 Taiwan Plant Derivative Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Plant Derivative Drugs Market Import-Export Trade Statistics |
7.1 Taiwan Plant Derivative Drugs Market Export to Major Countries |
7.2 Taiwan Plant Derivative Drugs Market Imports from Major Countries |
8 Taiwan Plant Derivative Drugs Market Key Performance Indicators |
8.1 Number of new plant derivative drug patents filed |
8.2 Investment in research and development of plant-based pharmaceuticals |
8.3 Number of clinical trials for plant derivative drugs conducted |
8.4 Consumer acceptance and satisfaction rates for plant-based medicines |
8.5 Adoption rates of plant derivative drugs by healthcare providers |
9 Taiwan Plant Derivative Drugs Market - Opportunity Assessment |
9.1 Taiwan Plant Derivative Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Plant Derivative Drugs Market Opportunity Assessment, By Therapeutics Application, 2021 & 2031F |
9.3 Taiwan Plant Derivative Drugs Market Opportunity Assessment, By Dosage Type, 2021 & 2031F |
9.4 Taiwan Plant Derivative Drugs Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Taiwan Plant Derivative Drugs Market - Competitive Landscape |
10.1 Taiwan Plant Derivative Drugs Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Plant Derivative Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here